New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The concept of mesenchymal fibroblasts has evolved over the past two decades from a relatively inert structural cell type to a dynamic, pluripotent cell lineage controlling normal connective tissue formation, homeostasis, and repair and as principle players in pathogenic scarring and fibrosis. In wound healing and tissue repair, fibroblasts provide proinflammatory signals and synthesize interstitial collagens, fibronectins, and other matrix components to repair the damaged tissue. Fibroblasts can differentiate into the myofibroblast, a specialized contractile cell type responsible for wound closure, tissue contraction, and scarring. This article reviews our current understanding of the origins of mesenchymal cells and their role in excessive scarring and fibrogenesis and in the systemic fibrotic disease scleroderma.
- New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma
Current Rheumatology Reports
Volume 9, Issue 2 , pp 136-143
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Author Affiliations
- 1. Centre for Rheumatology, Department of Medicine, Royal Free and University College Medical School, University College London (Hampstead Campus), Rowland Hill Street, London, NW3 2PF, UK